Nurix Therapeutics Inc (NASDAQ:NRIX) price on Friday, July 25, fall -0.09% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $11.52.
A look at the stock’s price movement, the close in the last trading session was $11.53, moving within a range at $11.45 and $11.7. The beta value (5-Year monthly) was 2.149. Turning to its 52-week performance, $29.56 and $8.18 were the 52-week high and 52-week low respectively. Overall, NRIX moved -0.86% over the past month.
Nurix Therapeutics Inc’s market cap currently stands at around $880.70 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that NRIX is a Hold. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
16 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 13 recommend NRIX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
NRIX’s current price about -4.20% and -0.11% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 46.09, while 7-day volatility ratio is 3.77% and 6.11% in the 30-day chart. Further, Nurix Therapeutics Inc (NRIX) has a beta value of 2.15. Analysts have given the company’s stock an average 52-week price target of $16, forecast between a low of $16 and high of $30. Looking at the price targets, the low is -38.89% off current price level while to achieve the yearly target high, price needs to move -160.42%. Nonetheless, investors will most likely welcome a -38.89% jump to $16 which is the analysts’ median price.
If we refocus on Nurix Therapeutics Inc (NASDAQ:NRIX), historical trading data shows that trading volumes averaged 0.75 over the past 10 days and 850.37K over the past 3 months. The company’s latest data on shares outstanding shows there are 76.43 million shares.
The 2.00% of Nurix Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 110.34% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 13.95 million on 2025-07-15, giving us a short ratio of 14.22. The data shows that as of 2025-07-15 short interest in Nurix Therapeutics Inc (NRIX) stood at 2143.0 of shares outstanding, with shares short falling to 14.44 million registered in 2025-06-13. Current price change has pushed the stock -49.03% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NRIX stock continues to rise going into the next quarter.
